172 related articles for article (PubMed ID: 23735729)
1. Blood pressure variability in chronic kidney disease patients.
Mallamaci F; Tripepi G
Blood Purif; 2013; 36(1):58-62. PubMed ID: 23735729
[TBL] [Abstract][Full Text] [Related]
2. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
[TBL] [Abstract][Full Text] [Related]
3. Association between visit-to-visit clinic blood pressure variability and home blood pressure variability in patients with chronic kidney disease.
Okada T; Wada T; Nagaoka Y; Kanno Y
Ren Fail; 2015 Apr; 37(3):446-51. PubMed ID: 25578817
[TBL] [Abstract][Full Text] [Related]
4. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.
Azushima K; Wakui H; Uneda K; Haku S; Kobayashi R; Ohki K; Kinguchi S; Haruhara K; Fujikawa T; Toya Y; Umemura S; Tamura K
Clin Exp Hypertens; 2017; 39(7):665-671. PubMed ID: 28635327
[TBL] [Abstract][Full Text] [Related]
5. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties.
Kovesdy CP
Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii219-ii223. PubMed ID: 28201651
[TBL] [Abstract][Full Text] [Related]
6. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
[TBL] [Abstract][Full Text] [Related]
7. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J
Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328
[TBL] [Abstract][Full Text] [Related]
8. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease.
Yokota K; Fukuda M; Matsui Y; Hoshide S; Shimada K; Kario K
Hypertens Res; 2013 Feb; 36(2):151-7. PubMed ID: 23013884
[TBL] [Abstract][Full Text] [Related]
9. CKD awareness and blood pressure control in the primary care hypertensive population.
Ravera M; Noberasco G; Weiss U; Re M; Gallina AM; Filippi A; Cannavò R; Ravera G; Cricelli C; Deferrari G
Am J Kidney Dis; 2011 Jan; 57(1):71-7. PubMed ID: 21087817
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
11. Home blood pressure monitoring in CKD.
Cohen DL; Huan Y; Townsend RR
Am J Kidney Dis; 2014 May; 63(5):835-42. PubMed ID: 24529535
[TBL] [Abstract][Full Text] [Related]
12. [New aspects of hypertension management in patients with chronic kidney disease].
Vakilzadeh N; Phan O; Forni Ogna V; Burnier M; Wuerzner G
Rev Med Suisse; 2014 Sep; 10(441):1668-72. PubMed ID: 25322626
[TBL] [Abstract][Full Text] [Related]
13. [Underestimated frequency of resistant hypertension in predialysis nondiabetic patients].
Prkacin I; Balenović D; Prkacin P; Jurina A; Santek L; Kasumović D; Cavrić G; Bulum T
Acta Med Croatica; 2012 Jul; 66(3):229-33. PubMed ID: 23441538
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of control of blood pressure in chronic kidney disease patients with hypertension attending echo-lab of Nepal Medical College Teaching Hospital.
Shrestha B; Dhungel S
Nepal Med Coll J; 2012 Jun; 14(2):118-24. PubMed ID: 23671961
[TBL] [Abstract][Full Text] [Related]
15. What should be the goal blood pressure in nondiabetic chronic kidney disease?
Schneider MP; Hilgers KF
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of hypertension in patients with chronic kidney disease.
Talreja H; Ruzicka M; McCormick BB
Am J Cardiovasc Drugs; 2013 Jun; 13(3):177-88. PubMed ID: 23553321
[TBL] [Abstract][Full Text] [Related]
17. [Limitations of blood pressure target in non-dialysis chronic kidney disease: a question of method?].
Borrelli S; De Nicola L; Minutolo R; Sagliocca A; Garofalo C; Liberti ME; Pacilio M; Iorio V; Michini C; Pirro L; Conte G
G Ital Nefrol; 2012; 29(4):418-24. PubMed ID: 22843154
[TBL] [Abstract][Full Text] [Related]
18. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
Weir MR; Zappe D; Orloski LA; Sowers JR
J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
[TBL] [Abstract][Full Text] [Related]
19. Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study).
Macdonald K; Brié H; Vancayzeele S; Lee C; Bowles J; Piotrowski K; Hermans C; Abraham I
Arch Cardiovasc Dis; 2013 Mar; 106(3):124-34. PubMed ID: 23582674
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease.
Schmitt KE; Edie CF; Laflam P; Simbartl LA; Thakar CV
Am J Nephrol; 2010; 32(6):541-8. PubMed ID: 21042012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
